A new report out of Denmark has helped clarify the safety concerns with the antibiotic azithromycin (Zithromax/Zmax, Pfizer). Earlier this year, an analysis of Medicate patients showed an increase risk of death in patients that used Zithromax vs those that used none or amoxicillin. The current study has concluded that on its own, Zithromax does NOT raise the risk of cardiovascular death in patients aged 18-64 years. This was based on 12 years if data.
Take home message:
- Zithromax is safe to use in patients younger than 65 years of age
- Zithromax does slightly raise the risk of CV death in patients older than 65 years of age